BridgeMD
New treatment option for Crohn Disease (CD)
Official title TIDHI Mental Health in IBD Patients Study
ClinicalTrials.gov ID: NCT07013578
What this study is testing
- What it's testing
- The purpose of this study is to test the impact of Healing Circuits™; a structured mental health support model on IBD patients. The eligible study participants will be randomly divided into two groups: 1.
- Time commitment: about 12 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- people must meet each of the following criteria for enrolment into the study:
- Written informed consent must be obtained and documented.
- Males and females between the ages of 18 and 75 years of age with documented diagnosis of IBD.
- GAD7 and/or PHQ9 score of 10 - 15.
- Ability of subject to participate fully in all aspects of this clinical trial.
You likely can't join if
- people who exhibit any of the following conditions are to be excluded from the study:
- Plan for change in systemically delivered IBD-related medical therapy in the 3 months after screening.
- Serious underlying psychiatric disorder such as schizophrenia or bipolar disorder.
- Planned change in psychiatric medication, if any is being taken, within 3 months after screening.
- History of illegal drug abuse (excluding marijuana) or alcohol abuse which in the opinion of the investigator may interfere with the subject's...
See the full eligibility criteria
- people must meet each of the following criteria for enrolment into the study:
- Written informed consent must be obtained and documented.
- Males and females between the ages of 18 and 75 years of age with documented diagnosis of IBD.
- GAD7 and/or PHQ9 score of 10 - 15.
- Ability of subject to participate fully in all aspects of this clinical trial.
- IBD patients who plan to have ongoing medical care at TIDHI.
- people who exhibit any of the following conditions are to be excluded from the study:
- Plan for change in systemically delivered IBD-related medical therapy in the 3 months after screening.
- Serious underlying psychiatric disorder such as schizophrenia or bipolar disorder.
- Planned change in psychiatric medication, if any is being taken, within 3 months after screening.
- History of illegal drug abuse (excluding marijuana) or alcohol abuse which in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures
The study team makes the final eligibility decision.
Where it's taking place
- North York, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include North York, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.